Are you Dr. Thomas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 13 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3075 Chestnut Run Dr
Bloomfield Hills, MI 48302Phone+1 248-253-0774Fax+1 947-522-0307
Summary
- Dr. Maria Thomas, MD is a board certified pathologist in Bloomfield Hills, Michigan. She is currently licensed to practice medicine in Michigan, Alabama, and Florida. She is affiliated with Corewell Health Dearborn Hospital.
Education & Training
- University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Cytopathology, 2003 - 2004
- Corewell Health East Beaumont (Royal Oak)Residency, Pathology-Anatomic and Clinical, 1998 - 2003
- University of Jos Faculty of MedicineClass of 1988
Certifications & Licensure
- FL State Medical License 2022 - 2026
- TN State Medical License 2022 - 2026
- AL State Medical License 2022 - 2025
- GA State Medical License 2022 - 2025
- NC State Medical License 2022 - 2025
- SC State Medical License 2022 - 2025
- MI State Medical License 1998 - 2024
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
- Join now to see all
Publications & Presentations
PubMed
- 349 citationsDeletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol DietJawahar L. Mehta, Nobuhito Sanada, Chang Ping Hu, Jiawei Chen, Abhijit Dandapat
Circulation Research. 2007-06-08 - 156 citationsGene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular ...Alessandro D. Santin, Fenghuang Zhan, Eliana Bignotti, Eric R. Siegel, Stefania Cane
Virology. 2005-01-20 - 103 citationsRacial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.Alessandro D. Santin, Stefania Bellone, Eric R. Siegel, Michela Palmieri, Maria Thomas
American Journal of Obstetrics and Gynecology. 2005-03-01